Portfolio: Highlights
MPM invests in biotechnology, specialty pharma, medical technology, and related companies that provide innovative medical products and requisite services to the healthcare industry -- irrespective of geography, stage of development and therapeutic area.
EKR Holdings, Inc.
Pain management and oncology products
Pacira Pharmaceuticals, Inc.
Sustained-release drug delivery technologies
Peplin Limited
Development and commercialisation of prescription therapeutic products for cancer patients
TriVascular2, Inc.
Novel endovascular repair devices to treat abdominal aortic aneurysms
BioMarin Pharmaceuticals
Biopharmaceuticals for serious diseases and medical conditions
Biovitrum AB
Biopharmaceuticals for metabolic & blood disorders
Caliper Technologies Corp.
Cutting edge technologies for life science researchers.
Idenix Pharmaceuticals, Inc.
Anti-HIV and HBV therapy
Intercell AG
Vaccines for the prevention and treatment of infectious diseases.
Omrix Biopharmaceuticals, Inc.
Innovative biosurgical and passive immunotherapy products
Pharmasset, Inc.
Anti-viral therapy
Rigel
Novel small-molecule drugs for inflammatory/autoimmune diseases and cancer.
ViaCell
Acquired by PerkinElmer
CoTherix
Acquired by Actelion
HemoSense
Acquired by Inverness Medical Innovations
Hypnion
Acquired by Lilly
Idenix Pharmaceuticals, Inc.
Groundbreaking partnership with Novartis
IDUN Pharmaceuticals, Inc.
Early acquisition by Pfizer
Rinat Neuroscience Corp.
Genentech spinout acquired by Pfizer
TransForm
Acquired by J&J
ViaCell
Acquired by PerkinElmer